New Zealand markets close in 2 hours 30 minutes

ALX Oncology Holdings Inc. (ALXO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.74-0.34 (-2.11%)
At close: 04:00PM EDT
15.33 -0.41 (-2.60%)
After hours: 07:31PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
1,182
Cost of revenue
-
-
0
0
1,075
Gross profit
-
-
0
0
107
Operating expenses
Research development
141,795
141,795
98,400
60,170
28,961
Selling general and administrative
28,483
28,483
29,036
23,385
14,809
Total operating expenses
170,278
170,278
127,436
83,555
43,770
Operating income or loss
-170,278
-170,278
-127,436
-83,555
-43,663
Interest expense
1,565
1,565
238
13
811
Total other income/expenses net
389
389
-22
-7
-1,960
Income before tax
-160,805
-160,805
-123,418
-83,484
-45,499
Income tax expense
0
0
64
-21
241
Income from continuing operations
-160,805
-160,805
-123,482
-83,463
-45,740
Net income
-160,805
-160,805
-123,482
-83,463
-45,740
Net income available to common shareholders
-160,805
-160,805
-123,482
-83,463
-50,942
Basic EPS
-3.57
-
-3.03
-2.07
-2.76
Diluted EPS
-3.57
-
-3.03
-2.07
-2.76
Basic average shares
40,909
-
40,700
40,308
18,485
Diluted average shares
40,909
-
40,700
40,308
18,485